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Tendinopathy is a common clinical problem and has a significant disease burden attached,
not only in terms of health care costs, but also for patients directly in terms of time off
work and impact upon quality of life. Controversy surrounds the pathogenesis of tendin-
opathy, however the recent systematic analysis of the evidence has demonstrated that
many of the claims of an absence of inflammation in tendinopathy were more based
around belief than robust scientific data. This review is a summary of the emerging
research in this topical area, with a particular focus on the role of neuronal regulation and
inflammation in tendinopathy.
© 2017 The Authors. Published by Elsevier Ltd on behalf of Royal College of Surgeons of
Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland.
This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).Introduction
Tendinopathy is a common clinical problem, the three most
common sites affected are the Achilles, patellar and rotator
cuff tendons.1 The rotator cuff tendons are the most
commonly affected with an annual incidence of over 1% that
increases with age2,4 and consequently there is a rising rate of
surgery for rotator cuff tears.5 Others include the tendons
around the elbow (golfer's and tennis elbow) and the tendonsm (B.J.F. Dean), stephani
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The pathogenesis of tendinopathy is certainly multifactorial
and complex.6,7 Increased age is a key risk factor for the
development of tendinopathy,8,9 although the commonly
affected tendons all experience high levels of mechanical
stress10 and over-use is a frequently implicated risk factor.8,11
The mechanism of overuse has been well demonstrated in
animal models,12,13 while both metabolic and vascular risk
factors are associated with the development of tendinop-
athy.9,14 Inactivity and the unloading also have an effect on
tendon collagen homeostasis.15
Recent systematic reviews have clearly demonstrated that
patients with high cholesterol and diabetes are at significantly
higher risk of developing tendinopathy,14,16 while recent re-
view has demonstrated that an association exists between the
metabolic-hormonal imbalances and tendon degeneration.17
Hypercholesterolaemia has also been demonstrated to have
a significant impact upon tendon repair in vivo,18 while the
clear link between hypercholesterolaemia and inflammation
has been long known.19 This emerging link betweenmetabolic
dysregulation and chronic inflammation in tendinopathy has
also been supported by a recent study using Achilles tendon
biopsies from a group of patients.20
The historical context relating to the rotator cuff provides
an interesting insight into the frequent debates and changing
viewpoints as regards tendinopathy pathogenesis. Codman
initially proposed in 193421 that degeneration within the
tendon was the ‘intrinsic’ primary causal factor. The
‘extrinsic’ theory relating to tendon damage secondary to
attrition by surrounding structures was popularised by Neer22
and the term ‘impingement’ was coined. Broadly the modern
consensus recognises both the role of intrinsic and extrinsic
factors, but sees the intrinsic factors as being more dominant
overall23 with the use of the term ‘impingement’ appearing
increasingly baseless.24 It is probable that different patients
have different disease phenotypes with different intrinsic and
extrinsic factors playing variable roles. Certainly not all ten-
dinopathies are identical, as represented by differences in
both the tendon's local anatomy and epidemiological profile.Histopathology and clinical features
Tendinopathy has characteristic histopathological, clinical
and radiological findings.25 The histopathological changes
include collagen disorganisation, the increased deposition of
mucoid ground substance, increased overall cellularity, as
well as the appearance of round and plump ‘chondroid’ type
cells.26,27 These features of apparent attempted healing
diminish as degree of tendon degeneration increase. The
overall picture is one of pathological chondroplasia in which
tissue which normally exhibits a tensional morphology is
replaced by tissue of a fibrocartilage-like phenotype.26,28 His-
torically several different words have been used to described
tendon related pathology including ‘tendinosis’ (implying
degenerative aetiology), ‘tendinitis’ (implying inflammatory
aetiology) and the more recently favoured and less aetiologi-
cally specific ‘tendinopathy’.29 This diversity of languagereflects a historical disagreement within the scientific com-
munity as to the exact role of inflammation in the aetiology of
‘tendinopathy’. Recent evidence has shown that tendon
overload is linked to alterations in cell shape, as well as
increasedmarkers of inflammation andmatrix degradation.30
The way in which the cells interact with the extracellular
matrix is an area of much interest31,32; inflammation and
damage-inducedmatrix remodelling seem to be concentrated
in, or in the vicinity of, the highly cellular interfascicular
matrix.33 It may be therefore be postulated that interactions
between the tendon, the interfascicular matrix and adjacent
fat pads are instrumental in the development of tendinop-
athy, with the latter being a key potential source of key cyto-
kines and inflammatory cells.34 This may help explain the
presence of persistent inflammation in tendinopathy,35 a
phenomenon which has been shown to have important ef-
fects on tendon cells in vitro.36,37
Clinical symptoms including pain are frequently poorly
matched to the histopathological and radiological findings,
meaning that a high proportion of patients with a tendon that
is both histopathologically and radiologically degenerate
experience have no related pain or symptoms.38 The reasons
for this mismatch between pathology and perceived pain are
poorly understood, however recent research has identified the
peripheral and central pain processing pathways as good
candidates for an explanation.39,40 It appears that the pres-
ence of pain in tendinopathy not only relates to mechanical
changes in the tendon but also changes to the ways in which
the local cells and the peripheral nerves react to this change,
thus contributing to the nociceptive pathways to higher cen-
tres being activated. Overall the vast majority of tendon
ruptures (97%) occur in patients with histopathologically
abnormal tendons.41Neuronal pathways and glutamate
The neuronal response to tendon injury involves nerve in
growth during the initial inflammatory phase; the subsequent
proliferative and remodelling phases are regulated by sensory
nerves, aswell as the glutaminergic and autonomic systems.42
Glutamate is an important amino acid involved in many key
physiological processes including cell metabolism, pain
sensitization and collagen synthesis.39,43 Glutamate receptors
can be broadly broken down into two major types: inotropic,
which are glutamate-gated ion channels (iGlu), and metabo-
tropic, which are G-protein coupled receptors that modulate
signal transduction cascades (mGlu).44 The inotropic re-
ceptors include Kainate (KA) receptors, a-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid (AMPA) receptors and N-
Methyl-D-Aspartate (NMDA) receptors.45 Glutamate has been
shown to induce pain and hyperalgesia when injected around
human tendon tissue.46 An upregulation of the glutaminergic
signalling has been linked to inflammatory change in a rat
supraspinatus model.47
The first study to recognize the presence of glutamate in
tendinopathy used a microdialysis technique in chronic
painful Achilles tendinopathy.48 Glutaminergic changes have
since become increasingly described in painful tendinop-
athy,42 including an increase in extracellular glutamate
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(NMDA) receptors.49,50 Recently the upregulation of the glu-
taminergic systemhas been confirmed to be present in rotator
cuff tendinopathy for the first time.51 This histological and
immunohistochemical study demonstrated that an increase
in glutamate staining was present in the painful tendino-
pathic rotator cuff tendons alongside the classical histological
changes which included increased collagen disorganization
and cellularity. Glutamate stainingwas distinctly expressed in
resident cells within the tendon. The release of glutamate
from tendon cells was first hypothesized by Scott et al.52 who
detected vesicular glutamate transporter expression in cells
localized in tendon tissue in lower limb tendinopathies. This
was later detected by Schizas et al.50 Because of the me-
chanical and structural differences between tendon locations,
it cannot be assumed that cell behaviour is uniform in both
upper and lower limb tendinopathies. This study has also
shown significant staining of certain ionotropic and metabo-
tropic receptors on tendon cells residing in damaged rotator
cuff tissue, for example NMDAR1 and mGluR1. This study did
not find any correlation with the severity of patient pain
symptoms. This is not unsurprising as previous studies have
failed to detect this link.53 Previous studies of tendon structure
has been shown to be a powerful predictor of the presence of
pain,38 but not of its severity.
Sensory neuropeptide expression has also been shown to
be associated with both failed healing and pain in an animal
model of tendon injury,54 they have also been causally linked
with tendinopathy-like changes in animal models.55,56 Neu-
ropeptides have pro-proliferative, angiogenic and stem cell-
stimulating properties in vitro,57 however little work had
been carried out to investigate the effects of glutamate on
tendon derived cells. Dean et al. exposed tendon derived cells
from both healthy controls and patients with tendinopathy to
different concentrations of glutamate and specific glutamate
receptor inhibitors.58 Tendon derived cell viability was
reduced after 72 h of exposure to relatively low concentrations
of glutamate (0.05 mM and 1.875 mM) and this deleterious
effect was attenuated by NMDAR antagonism. Higher con-
centrations of glutamate reduced cell viability at 24 h in
tendon tear derived cells and not in control cells. A reduction
in collagen (COL1A1 and COL3A1) and increase in aggrecan
gene expression were seen after both 24 and 72 h of glutamate
exposure. Overall the in vitro effects of glutamate in terms of
reducing cell viability, decreasing collagen gene expression
and increasing aggrecan gene expression suggested that the
raised levels of glutamate contributes to the pathogenesis of
tendinopathy.Clinical meaning of neuronal changes
Tendon samples from patients with persistent pain demon-
strated increased levels of metabotropic glutamate receptor 2
(mGluR2), Kainate receptor 1 (KA1), Protein Gene Product 9.5
(PGP9.5), CD206 (macrophage marker) and CD45 (pan-leuco-
cyte marker) versus pain-free controls.59 Notably the painful
and pain-free patient groups were matched in terms for basic
demographic and tendon structure, while there were no dif-
ferences between groups in terms of the basic histology.NMDAR1 co-localised with CD206 positive cells, whereas
PGP9.5 and glutamate were predominantly expressed by
resident tendon cells. Within the gene expression data related
to cells derived from rotator cuff years there were strong
correlations between CD206 expression and glutamate re-
ceptor expression. This work demonstrated an association
between glutaminergic and pro-inflammatory changes in
tendon cells and pain. To our knowledge this is the first his-
tological study that has used structurally and age matched
tendon from pain-free tendinopathic patients as a control.
The co-localisation of NMDAR1 and CD206 suggests that
certain glutamate receptors are predominantly expressed on
‘inflammatory’ type cells within tendon.
Recent in vivo work by Valkering et al. has investigated the
role of glutamate in Achilles tendon healing following acute
Achilles tendon rupture.60 Patients were randomised into two
groups, and those in the functional weight bearing group had
significantly higher levels of glutamate than the non-weight
bearing group, while the higher glutamate levels correlated
with both the level of the marker of procollagen type I (PINP)
and improved functional outcome at six months. Substance P
enhances cell proliferation and sensory nerve in growth in the
rat,61 conversely joint immobilisation has been shown to
reduce the expression of sensory neuropeptides in the rat and
this is associated with significantly poorer tendon healing.62
In clinical terms glutamate appears important in normal
tendon healing,63 while its upregulation in tendinopathy ap-
pears consistent with an environment of persistently failing
healing and perhaps a failure of inflammation to resolve.The emergence of inflammation
The dwindling of popularity of the term ‘tendinitis’ repre-
sented skepticism regarding the role of inflammation in
tendon degeneration. Recent systematic analysis of the evi-
dence has demonstrated that many of the claims of an
absence of inflammation in tendinopathy were more based
around belief than robust scientific data.29 Several studies
have stated that ‘no inflammatory cells’ were present in
samples from tendinopathic patients but had only looked for
neutrophils, not other types of ‘inflammatory cell’. In fact the
evidence to support the role of inflammation in tendinopathy
pathogenesis has become increasingly overwhelming in
recent years with a majority of studies demonstrating
increased numbers of macrophages in diseased tendons.29
Macrophages are known to play an essential role orches-
trating inflammation and tissue repair. The signalling path-
ways underpinning activation of macrophages to become M1
or M2 subtypes have been revised to identify the signalling
pathways underpinning macrophage activation interferon,
NF-kB, (STAT6) and glucocorticoid receptor activation path-
ways.64 Thesemacrophage activation pathways have recently
been identified in samples of diseased human rotator cuff
tendons. Tendon tissues from patients with early stage dis-
ease showed increased expression of genes and proteins
induced by Interferons and NF-kB37. Conversely, tendons from
patients with advanced stage disease (large to massive tears)
showed expression of genes and proteins induced by STAT6
and glucocorticoid receptor activation pathways. These
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in diseased tendons and how they might change with the
stage of disease.
Increasing evidence has shown that inflammatory mech-
anisms and the innate immune system are activated within
the tendonmatrixmicroenvironment during tissue injury and
dysregulated homeostasis. An essential component of the
regulatory process that drives tendon remodelling includes
cytokines that dictate cell type and tissue specificity of re-
sponses that ultimately balance a reparative versus degener-
ative process. Endogenous expression of TNFa, IL-1b, IL-6, IL-
10, VEGF and TGFb has been demonstrated in tenocytes65e68
while diseased human tendon has shown expression of
Such expression is functionally implicated in vivo: for
example, the mechanical properties of healing tendons in IL-
6/ mice were inferior compared with littermate controls.69
Recent mechanistic dissection has highlighted a role for
the cytokine IL-33, a member of the IL-1 cytokine family that
plays a major role in innate and acquired immune responses,
in matrix/inflammatory crosstalk in tendon damage.70 IL-33
message and protein expression was significantly increased
in early human tendinopathy compared to both established
tendinopathy and normal tendon while the addition of exog-
enous IL-33 to in vitro human tenocyte cultures resulted in
increased expression of type I but particularly type III collagen
mRNA/protein. Moreover, an in vivo patellar tendon injury
model the addition of IL-33 significantly reduced the tendon
strength (load to failure) of WT mice by ~30% at early time
points, likely as a consequence of the concomitant collagen 3
matrix changes, which result in mechanically inferior tendon.
Taken together these studies demonstrate a key functional
role for IL-33 in early injury inducedmatrix dysregulation and
subsequent cytokine feedback mechanisms that have an ul-
timate biomechanical and clinical effect.
Emerging studies highlight microRNAs(miR) as key regu-
lators of leukocyte function and the cytokine network while
orchestrating proliferation and differentiation of stromal lin-
eages that determine extracellular matrix composition.71 We
identified reduced expression of mio-29a, which directly tar-
gets numerous extracellular matrix genes and is implicated in
the regulation of innate and adaptive immunity, in human
biopsies and demonstrated that its reduction leads to devel-
opment of tendinopathy. In human tenocytes, miR-29a was
only capable of influencing the expression of collagen type 3
and not type 1. This work has been expanded to an equine
tendinopathy model,72 considered equivalent to human dis-
ease, reinforcing that injury-induced loss of miR-29a is
responsible for the over-expression of col3 seen in equine
tendinopathy. Collectively these data suggest that the rein-
troduction of miR-29a to the injury-induced miR-29a defi-
ciency in tendon could reverse the key collagen switch that
remains a core pathological feature of tendinopathy. Thus
while the functional contribution of cytokine biology and its
downstream consequences in tendinopathy remains to be
established there is now a convincing scientific rationale to-
wards translational immunobiology to benefit tendinopathy
patients.73 The short term benefits of anti-inflammatory drug
treatments in tendinopathy have been demonstrated in the
short term,74 however there remains a distinct lack of effec-
tive long term treatments of any form.75Conclusions
Fundamentally a better understanding of the pathogenesis of
tendinopathy and the underlyingmechanisms is essential if we
are to developmore effective long term treatment strategies for
the management of tendinopathy.76,77 Our improved under-
standingwhich includes thiswork relating to theemerging roles
of the glutaminergic and inflammatory systems means that
more effective novel treatmentsmay be just around the corner.Sources of financial support
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